Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the Knee

PHASE3CompletedINTERVENTIONAL

Enrollment

288

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

PainOsteoarthritis, HipOsteoarthritis, Knee

Interventions

DRUG

OROS hydromorphone HCl

4 to 32 mg taken orally once daily for 16 weeks

DRUG

Placebo

placebo tablet once daily for 16 weeks

Trial Locations (12)

Klatovy

Olomouc

Pelhøimov

Prague

Roudnice nad Labem

Bucharest

Cluj-Napoca

Iași

Bratislava

Hlohovec

Piešťany

London